New Amsterdam Genomics Inc is a pioneering company based in Cambridge, MA, that is revolutionizing the field of medicine through the integration of data, statistics, and artificial intelligence (AI). Their advanced AI platform analyzes DNA sequencing data, lab values, and other health properties to create personalized care plans, resulting in life-changing reports for 45% more clients than any other DNA test.
With a focus on optimizing health and maximizing longevity, New Amsterdam Genomics provides a comprehensive view of an individual's genome, examining all 22,000 genes compared to other tests that only analyze a few. Their platform utilizes natural language processing to extract relevant information from medical papers, linking findings to actionable recommendations for doctors and empowering clients to proactively address their highest health risks.
Generated from the website